Skip to main content
search

Preclinical

Sign up

Latest resources

Featured resource

CERTAINTY 2025: The power of Model-Informed Drug Development
CERTAINTY 2025: The power of Model-Informed Drug DevelopmentBlog

CERTAINTY 2025: The power of Model-Informed Drug Development

We cover the key takeaways from CERTAINTY 2024, including the power of Model-Informed Drug Development and the role of AI in reducing time to…

Preclinical resources

QSP Summit 2025: A New Standard in the Future of Drug Development
QSP Summit 2025: A New Standard in the Future of Drug DevelopmentBlog

QSP Summit 2025: A New Standard in the Future of Drug Development

May 5, 2025 The Quantitative Systems Pharmacology (QSP) Summit 2025, hosted by Certara, marked another milestone in advancing the future of model-informed drug development.…
Explore First: How a Stepwise Approach to QTc Studies Reduces Time, Cost, and Regulatory Risk
Explore First: How a Stepwise Approach to QTc Studies Reduces Time, Cost, and Regulatory RiskWebinar

Explore First: How a Stepwise Approach to QTc Studies Reduces Time, Cost, and Regulatory Risk

Jul 24, 2025 - 11am ET
Essentials of Model-informed Drug Development in Oncology
Essentials of Model-informed Drug Development in OncologyBlog

Essentials of Model-informed Drug Development in Oncology

Model-informed drug development in oncology is critical to developing safer and more effective cancer drugs. Read the blog to learn…
A translational model-based meta-analysis to predict tremor incidence associated with serotonin reuptake transporter inhibition
A translational model-based meta-analysis to predict tremor incidence associated with serotonin reuptake transporter inhibitionPublication

A translational model-based meta-analysis to predict tremor incidence associated with serotonin reuptake transporter inhibition

The serotonin reuptake transporter (SERT) is responsible for the removal and recycling of the neurotransmitter serotonin from neuronal synapses and…

Latest preclinical blogs

All Preclinical resources

CERTAINTY 2025: The power of Model-Informed Drug Development

event, Late clinical - blog, Modeling and Simulation, Blog

Extrapolating AUC to Infinity

Certara Products - Phoenix, Modeling and Simulation - PK/PD, Blog, Knowledge Base

Bio International Convention 2025

Conference

Certara’s Simcyp Educational Webinar Series: Learn from A to Z of PBBM Part 2: What is the Drug Absorption Model?

Certara Products - Simcyp, Modeling and Simulation - PBPK, Webinar

QSP Summit 2025: A New Standard in the Future of Drug Development

Modeling and Simulation - QSP, Blog

Explore First: How a Stepwise Approach to QTc Studies Reduces Time, Cost, and Regulatory Risk

Modeling and Simulation, Webinar - Resources LP - Upcoming, Webinar

Essentials of Model-informed Drug Development in Oncology

Certara Products - Simcyp, Modeling and Simulation - PBPK, Pharmacometrics, Quantitive Systems Pharmacology (QSP), Blog

A translational model-based meta-analysis to predict tremor incidence associated with serotonin reuptake transporter inhibition

Model-Based Meta-Analysis (MBMA), Modeling and Simulation - QSP, Publication

Non-Animal Navigator™: Expert strategy and AI-enabled biosimulation to reduce, refine, or replace animal studies

Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Fact Sheet

Outsourcing in Clinical Trials East Coast 2025

Conference - Regulatory LP, Conference

Interactions of Therapeutic Antibodies With Presynaptically-Released Misfolded Proteins in Neurodegenerative Diseases. A Spatial Monte-Carlo Simulation Study

Modeling and Simulation - QSP, Publication

RAPS Sponsored Webcast: Regulatory Writing and Operations to Accelerate Submissions

Certara Services, Webinar
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.